Sage Therapeutics, Inc.
C17, C20, and C21 substituted neuroactive steroids and their methods of use
Last updated:
Abstract:
Described herein are neuroactive steroids or a pharmaceutically acceptable salt thereof. Such compounds are envisioned, in certain embodiments, to behave as GABA modulators. Also provided are pharmaceutical compositions comprising a compound described herein and methods of use and treatment, e.g., such as for inducing sedation and/or anesthesia.
Status:
Grant
Type:
Utility
Filling date:
11 Jul 2017
Issue date:
26 Jul 2022